| Assay ID | Title | Year | Journal | Article |
|---|
| AID232359 | Ratio of CD50 and ED50 values against inhibition of HIV in MT-4 cells | 1989 | Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
| Nucleic acid related compounds. 57. Synthesis, x-ray crystal structure, lipophilic partition properties, and antiretroviral activities of anomeric 3'-azido-2',3'-dideoxy-2,6-diaminopurine ribosides. |
| AID452273 | Ratio of compound EC50 to AZG EC50 for HIV1 LAI infected in human PBM cells after 5 days | 2010 | Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
| Synthesis and evaluation of 3'-azido-2',3'-dideoxypurine nucleosides as inhibitors of human immunodeficiency virus. |
| AID141915 | Toxic dose required to cause an alteration of normal C3H cell morphology | 1989 | Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
| Nucleic acid related compounds. 57. Synthesis, x-ray crystal structure, lipophilic partition properties, and antiretroviral activities of anomeric 3'-azido-2',3'-dideoxy-2,6-diaminopurine ribosides. |
| AID141914 | Effective dose required to inhibit MSV-induced transformation in murine C3H cells | 1989 | Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
| Nucleic acid related compounds. 57. Synthesis, x-ray crystal structure, lipophilic partition properties, and antiretroviral activities of anomeric 3'-azido-2',3'-dideoxy-2,6-diaminopurine ribosides. |
| AID28386 | Partition coefficient in 1-octanol and 10 mM aqueous potassium phosphate buffer at pH 7.4 | 1989 | Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
| Nucleic acid related compounds. 57. Synthesis, x-ray crystal structure, lipophilic partition properties, and antiretroviral activities of anomeric 3'-azido-2',3'-dideoxy-2,6-diaminopurine ribosides. |
| AID452272 | Cytotoxicity against african green monkey Vero cells after 5 days | 2010 | Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
| Synthesis and evaluation of 3'-azido-2',3'-dideoxypurine nucleosides as inhibitors of human immunodeficiency virus. |
| AID452274 | Ratio of compound EC90 to AZG EC90 for HIV1 LAI infected in human PBM cells after 5 days | 2010 | Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
| Synthesis and evaluation of 3'-azido-2',3'-dideoxypurine nucleosides as inhibitors of human immunodeficiency virus. |
| AID89115 | Cytotoxic dose required to inhibit HIV-induced cytopathogenicity in human MT-4 cells | 1989 | Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
| Nucleic acid related compounds. 57. Synthesis, x-ray crystal structure, lipophilic partition properties, and antiretroviral activities of anomeric 3'-azido-2',3'-dideoxy-2,6-diaminopurine ribosides. |
| AID452269 | Antiviral activity against HIV1 LAI infected in human PBM cells after 5 days | 2010 | Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
| Synthesis and evaluation of 3'-azido-2',3'-dideoxypurine nucleosides as inhibitors of human immunodeficiency virus. |
| AID452271 | Cytotoxicity against human CEM cells after 5 days | 2010 | Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
| Synthesis and evaluation of 3'-azido-2',3'-dideoxypurine nucleosides as inhibitors of human immunodeficiency virus. |
| AID89116 | Effective dose required to inhibit HIV-induced cytopathogenicity in human MT-4 cells | 1989 | Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
| Nucleic acid related compounds. 57. Synthesis, x-ray crystal structure, lipophilic partition properties, and antiretroviral activities of anomeric 3'-azido-2',3'-dideoxy-2,6-diaminopurine ribosides. |
| AID452270 | Cytotoxicity against human PBMC after 5 days | 2010 | Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
| Synthesis and evaluation of 3'-azido-2',3'-dideoxypurine nucleosides as inhibitors of human immunodeficiency virus. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |